As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
If your constipation lasts for more than 3 days, speak with your doctor about options to help. You might need to add a stool ...
New Scientist on MSN21h
GLP-1 drugs like Ozempic and Wegovy lower the risk of 42 conditionsThe benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
In all, researchers found that people taking GLP-1 medications had lower risks for 42 health outcomes, including liver ...
Medpage Today on MSN2d
GLP-1 Agents' Risks and Benefits Broader Than Previously ThoughtGLP-1 agents "have an intricate web of various effects," Al-Aly said in a press briefing. For example, the analysis showed ...
Novo Nordisk ( NYSE:NVO) and Eli Lilly ( NYSE:LLY) are making headlines againthis time, for potential benefits beyond weight ...
Hosted on MSN3h
GLP-1 Drugs Cut Risk of Alzheimer's, NVO & LLY Shares RiseThe stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...
Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for thyroid cancer ...
Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform ...
With a strategic focus on innovation and a robust operational framework, Medifast is well-placed for growth in the weight loss and GLP-1 medication space.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback